CARLSBAD, Calif. -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, announces Mark McDonough as Chair of the Board, the retirement of former Chair Carol Gallagher, Pharm.D., and the appointment of Michele Park, Ph.D. to the Board. Mark McDonough, CEO of ChromaCode, becomes Chair of the Board, effective January 1, 2024. Retiring Chair, Carol Gallagher commented, [...]

Oxford Instruments plc (“the Group”, “Oxford Instruments”), a leading provider of high technology products and services to industry and scientific research communities, today announces the acquisition of First Light Imaging SAS (“First Light”), a scientific camera specialist.  Based near Aix-en-Provence, France, and founded in 2011, First Light specialises in the design and manufacture of high-speed, [...]

Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions MARLBOROUGH, Mass. -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced the establishment of its Scientific Advisory Board (SAB) to provide strategic guidance and consult on the Company's efforts to [...]

NEWARK, Delaware -- QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials, and clinical research services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics in Europe. QPS announces an expanded and upgraded fleet of mass spectrometers, with the addition of a new TripleTOF® 6600+ for GLP [...]

Life science researchers can use DNAnexus’ Precision Health Data Cloud to analyze high-value omics data and quickly gain insights that pave the way for innovative discoveries MOUNTAIN VIEW, Calif., & PORTLAND, Maine -- DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Ovation, an omics data company committed to accelerating the development of precision [...]

Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives Cambridge, UK: Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell and gene therapies (CGTs), has today announced the formation of its [...]

New collaborative research center based at University of California, Berkeley, plans to develop platform approaches that can be easily modified to develop gene-editing medicines for hundreds of devastating illnesses Innovative model aims to dramatically reduce preclinical and clinical development time and expense for investigational rare disease therapies that currently struggle to attract funding Nobel laureate Doudna [...]

Goal to combine Ultima’s highly sensitive, low-cost technology with Quest’s oncology expertise and national scale in order to improve patient access, affordability and outcomes FREMONT, Calif & SECAUCUS, N.J. -- Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics (NYSE: DGX), the nation’s leading provider of diagnostic information services, today announced [...]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched a brand spanking new version of its hit product Stunner today. Stunner is the first instrument of its kind for the characterization of lipid nanoparticles (LNPs), racking up sizing, particle concentration, payload [...]

IK Partners (“IK”) and Mérieux Equity Partners (“MxEP”) are pleased to announce that the IK Small Cap II Fund and Mérieux Participations 3 have signed an agreement to sell their respective stakes in Mabtech AB (“Mabtech” or “the Company”), a Swedish biotechnology firm specialising in immune monitoring, to EQT. Financial terms of the contemplated transaction [...]